James T. Symanowski

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

Medicine, Oncology, Pharmacology +13

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B₁₂ as Front-Line Therapy in Malignant Pleural Mesothelioma

Giorgio V. Scagliotti, Dong-M. Shin, Hedy L. Kindler et al. · Journal of Clinical Oncology · 2003 · 255 citations

Medicine, Pharmacology, Pharmacotherapy +17

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2023 · 253 citations

Medicine, Oncology, Pharmacology +13

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 233 citations

Medicine, Oncology, Pharmacology +16

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Claire S. Zhu, Paul F. Pinsky, Daniel W. Cramer et al. · Cancer Prevention Research · 2011 · 187 citations · Full text

Medicine, Gynecology, Oncology +17